Your browser doesn't support javascript.
loading
Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study.
Sirijatuphat, Rujipas; Manosuthi, Weerawat; Niyomnaitham, Suvimol; Owen, Andrew; Copeland, Katherine Kradangna; Charoenpong, Lantharita; Rattanasompattikul, Manoch; Mahasirimongkol, Surakameth; Wichukchinda, Nuanjun; Chokephaibulkit, Kulkanya.
Afiliação
  • Sirijatuphat R; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Manosuthi W; Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand.
  • Niyomnaitham S; Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Owen A; Siriraj Institute of Clinical Research (SICRES), Mahidol University, Bangkok, Thailand.
  • Copeland KK; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
  • Charoenpong L; Mahidol University International College, Salaya, Thailand.
  • Rattanasompattikul M; Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand.
  • Mahasirimongkol S; Medical Department, Golden Jubilee Medical Centre, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Wichukchinda N; Division of Genomic Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
  • Chokephaibulkit K; Division of Genomic Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
Emerg Microbes Infect ; 11(1): 2197-2206, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35997325
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Tailândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Tailândia